Literature DB >> 3045437

Acute interstitial nephritis: immunologic and clinical aspects.

R M Ten1, V E Torres, D S Milliner, T R Schwab, K E Holley, G J Gleich.   

Abstract

Acute interstitial nephritis is a common renal syndrome that may be associated with a variety of infections and drug therapies or may develop without an identified cause. Three cases are presented to illustrate the three types of acute interstitial nephritis--drug related, infection related, and idiopathic. Cell-mediated immune mechanisms seem to be more important than humorally mediated mechanisms in the pathogenesis of acute interstitial nephritis. Frequently, eosinophils are identified as a component of the interstitial cellular infiltrate, and eosinophiluria and eosinophilia have been claimed to be helpful in the diagnosis of acute interstitial nephritis, especially the drug-induced type. Neither eosinophiluria nor the presence of increased urinary levels of eosinophil major basic protein, however, is specific for the diagnosis of acute interstitial nephritis. Patients with drug-induced interstitial nephritis frequently have symptoms and signs suggestive of a hypersensitivity syndrome and rarely have more dramatic anaphylactic manifestations. Systemic glucocorticoids have been shown to be beneficial in this type of acute interstitial nephritis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3045437     DOI: 10.1016/s0025-6196(12)62697-4

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  9 in total

1.  Drug-induced granulomatous interstitial nephritis in a pediatric patient.

Authors:  James E Tong; David N Howell; John W Foreman
Journal:  Pediatr Nephrol       Date:  2006-10-13       Impact factor: 3.714

Review 2.  Drug-induced nephrotoxicity. Aetiology, clinical features and management.

Authors:  A J Hoitsma; J F Wetzels; R A Koene
Journal:  Drug Saf       Date:  1991 Mar-Apr       Impact factor: 5.606

3.  Acute interstitial nephritis after COVID-19 vaccination.

Authors:  Felicia Sc Tan; Mohammad E Kabir; Sunil Bhandari
Journal:  BMJ Case Rep       Date:  2022-05-19

Review 4.  The role of active metabolites in drug toxicity.

Authors:  M Pirmohamed; N R Kitteringham; B K Park
Journal:  Drug Saf       Date:  1994-08       Impact factor: 5.606

Review 5.  Tubulointerstitial nephritis.

Authors:  C L Jones; A A Eddy
Journal:  Pediatr Nephrol       Date:  1992-11       Impact factor: 3.714

6.  Infection associated acute interstitial nephritis; a case report.

Authors:  Rupesh Raina; Shirisha Ale; Tushar Chaturvedi; Luke Fraley; Robert Novak; Natthavat Tanphaichitr
Journal:  J Nephropathol       Date:  2016-10-25

7.  Eosinophilia and risk of incident end stage kidney disease.

Authors:  Anam Tariq; Keisuke Okamato; Azka Tariq; Avi Z Rosenberg; Karim M Soliman; David W Ploth; Mohamed G Atta; Blaithin A McMahon
Journal:  BMC Nephrol       Date:  2020-01-13       Impact factor: 2.388

8.  Proton pump inhibitors and acute kidney injury: a nested case-control study.

Authors:  Donald G Klepser; Dean S Collier; Gary L Cochran
Journal:  BMC Nephrol       Date:  2013-07-16       Impact factor: 2.388

9.  Sildenafil Induced Acute Interstitial Nephritis.

Authors:  Ryan Burkhart; Nina Shah; Matthew Lewin
Journal:  Case Rep Nephrol       Date:  2015-09-27
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.